Video: Tarek Dessouky, MD, MBA, MPH, Executive Director, Innovative Clinical Research Institute (ICRI) talks about the research arm of The Oncology Institute (TOI) and discusses clinical trials as well as their benefits.
A clinical trial is a voluntary study conducted in individuals to answer specific questions about the safety and/or effectiveness of new drugs, vaccines or other therapies.
Clinical trials are conducted in four phases – which include assessing safety, efficacy, as well as potential side effects. The FDA requires clinical trials before any kind of medicine can be approved for the general population. The Oncology Institute does not accept any trials they feel will not benefit their patients.
By taking part in a clinical trial, participants gain access to new, state-of-the-art cancer treatments. Participants also play a more active role in their treatment and researchers follow their health journey a bit more closely.
“Our goal at the Innovative Clinical Research Institute, ICRI, is to be able to offer every one of our patients the opportunity to participate in a clinical trial if they wish.” -Dr. Tarek Dessouky, Executive Director, Innovative Clinical Research Institute (ICRI)
The Innovative Clinical Research Institute (ICRI) at TOI
Innovative Clinical Research Institute (ICRI) is the research arm of The Oncology Institute of Hope and Innovation. They are a leader in the field of cancer clinical trials, a network of compassionate, experienced cancer care specialists.
ICRI was founded in 2011. Since then, they have been committed to advancing and innovating cancer treatment through cutting-edge clinical trials. Their goal is to assist in the process of discovering safe and effective therapies that improve the quality of life in cancer patients in the U.S. and around the world.
Want more information on clinical trials?
Discover a clinical trial that might be right for you
